Subscribe to IPO Boutique to know which deals are generating the most demand and which offering you should indicate for!
Check out the IPO Boutique Pipeline Page HERE!
Wednesday (10/06) Debut
- iFIT Health & Fitness Inc (IFIT) — They are a health and fitness subscription technology company, fueled by their passion to innovate, grow and provide meaningful solutions for their members. iFIT is an integrated health and fitness platform, designed to connect their proprietary software, experiential content and interactive hardware to deliver an unmatched connected fitness experience. The company is seeking a market cap of $5.7b-$6.6b based on the $18-$21 range. Link to Prospectus: Terms Added: 9-27-21
Thursday (10/07) Debut
Cingulate Inc (CING) — They are a clinical stage biopharmaceutical company using their proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company is seeking a market cap of $204m-$246m based on the $10-$12 range. Link to Prospectus: Terms Added: 9-27-21
Life Time Group Holdings Inc (LTH) — They are a leading lifestyle brand offering premium health, fitness and wellness experiences to a community of nearly 1.4 million individual members, who together comprise more than 767,000 memberships, as of July 31, 2021. The company is seeking a market cap of $3.6b-$4.15b based on the $18-$21 range. Link to Prospectus: Terms Added: 9-29-21
Theseus Pharmaceuticals Inc (THRX) — They are a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company is seeking a market cap of $502m-$574m based on the $14-$16 range. Link to Prospectus: Terms Added: 9-30-21
Friday (10/8) Debut
- Cognition Therapeutics, Inc. (CGTX) — They are a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. The company is seeking a market cap of $194m-$229m based on the $11-$13 range.
-
IsoPlexis Corporation (ISO) — They are enabling deeper access to in vivo biology and driving durable and potentially transformational research on disease in a new era of advanced medicine. The company is seeking a market cap of $544m-$622m based on the $14-$16 range.
- Pyxis Oncology, Inc. (PYXS) — They are a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The company is seeking a market cap of $428m-$489m based on the $14-$16 range.
Indicating for IPOs or Secondary offerings? Place IPO Boutique on your team.
https://www.ipoboutique.com/blog/register/
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish